Literature DB >> 9916784

Secondary osteoporosis and the risk of vertebral deformities in women.

L J Melton1, E J Atkinson, S Khosla, W M O'Fallon, B L Riggs.   

Abstract

Among an age-stratified sample of 942 Rochester, MN women, the overall prevalence of any vertebral deformity, as assessed by radiographic morphometry, was 21.3 per 100. The prevalence increased with age and, after adjusting for age, vertebral deformities were independently associated with height, weight, a history of distal forearm or hip fractures, and anticoagulant use. Altogether, 73% of the women with a vertebral deformity and 66% of controls had one or more of the conditions that have been linked with secondary osteoporosis, which in aggregate were associated with an age-adjusted 1.2-fold (95% CI 0.8-1.7) increase in risk that was not statistically significant. The prevalence of severe vertebral deformities was 11.7 per 100 women and the prevalence of very severe deformities was 5.7 per 100. There was a stronger relationship of age and most other risk factors with severe vertebral deformities than with isolated mild deformities, suggesting that a subset of mild deformities may not represent actual vertebral fractures. The metabolic disorders linked with secondary osteoporosis were associated with little increase in the risk of severe vertebral deformities, taken together, or of mild deformities. However, in aggregate these conditions were associated with a 2.3-fold increase (95% 1.1-4.8) in very severe vertebral deformities, which points to a role for rapid cancellous bone loss among women with the worst spinal osteoporosis.

Entities:  

Mesh:

Year:  1999        PMID: 9916784     DOI: 10.1016/s8756-3282(98)00150-1

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  10 in total

1.  Influence of baseline deformity definition on subsequent vertebral fracture risk in postmenopausal women.

Authors:  L J Melton; D E Wenger; E J Atkinson; S J Achenbach; T H Berquist; B L Riggs; G Jiang; R Eastell
Journal:  Osteoporos Int       Date:  2006-04-28       Impact factor: 4.507

Review 2.  Identification of vertebral fractures: an update.

Authors:  L Ferrar; G Jiang; J Adams; R Eastell
Journal:  Osteoporos Int       Date:  2005-05-03       Impact factor: 4.507

Review 3.  Bone disease in HIV infection: a practical review and recommendations for HIV care providers.

Authors:  Grace A McComsey; Pablo Tebas; Elizabeth Shane; Michael T Yin; E Turner Overton; Jeannie S Huang; Grace M Aldrovandi; Sandra W Cardoso; Jorge L Santana; Todd T Brown
Journal:  Clin Infect Dis       Date:  2010-10-15       Impact factor: 9.079

4.  Mortality in the vertebroplasty population.

Authors:  R J McDonald; S J Achenbach; E J Atkinson; L A Gray; H J Cloft; L J Melton; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2011-10-13       Impact factor: 3.825

5.  Use of renal function measurements for assessing fracture risk in postmenopausal women.

Authors:  James T McCarthy; Andrew D Rule; Sara J Achenbach; Eric J Bergstralh; Sundeep Khosla; L Joseph Melton
Journal:  Mayo Clin Proc       Date:  2008-11       Impact factor: 7.616

6.  Trabecular bone scores and lumbar spine bone mineral density of US adults: comparison of relationships with demographic and body size variables.

Authors:  A C Looker; N Sarafrazi Isfahani; B Fan; J A Shepherd
Journal:  Osteoporos Int       Date:  2016-03-07       Impact factor: 4.507

7.  Fracture risk in type 2 diabetes: update of a population-based study.

Authors:  L Joseph Melton; Cynthia L Leibson; Sara J Achenbach; Terry M Therneau; Sundeep Khosla
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

8.  Tubal ligation and the risk of vertebral fractures.

Authors:  Grace Wyshak
Journal:  Osteoporos Int       Date:  2004-09-29       Impact factor: 4.507

9.  Long-term fracture risk following adult-onset asthma: a population-based study.

Authors:  L Joseph Melton; Ashok Patel; Sara J Achenbach; Ann L Oberg; John W Yunginger
Journal:  Osteoporos Int       Date:  2004-02-24       Impact factor: 4.507

10.  Markers of autoimmune liver diseases in postmenopausal women with osteoporosis.

Authors:  Umit Secil Demirdal; Ihsan Hakkı Ciftci; Vural Kavuncu
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.